BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23475845)

  • 1. Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.
    Rollins-Raval MA; Fisher J; Craig FE
    Cytometry B Clin Cytom; 2013 May; 84(3):149-56. PubMed ID: 23475845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of lysis solutions on absolute CD19+ lymphocytes count and CD45 index in chronic lymphocytic leukemia.
    Mekouar H; Mullier F; Dinon Q; Bailly N; Cornet Y; Chatelain B
    Cytometry B Clin Cytom; 2011 Nov; 80(6):369-72. PubMed ID: 21638772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
    Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
    Sokol L; Agosti SJ
    Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
    Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
    Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia with low lymphocyte count.
    Batata A; Shen B
    Cancer; 1993 May; 71(9):2732-8. PubMed ID: 7682147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia.
    Marti GE; Carter P; Abbasi F; Washington GC; Jain N; Zenger VE; Ishibe N; Goldin L; Fontaine L; Weissman N; Sgambati M; Fauget G; Bertin P; Vogt RF; Slade B; Noguchi PD; Stetler-Stevenson MA; Caporaso N
    Cytometry B Clin Cytom; 2003 Mar; 52(1):1-12. PubMed ID: 12599176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
    Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
    Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.
    Nieto WG; Teodosio C; López A; Rodríguez-Caballero A; Romero A; Bárcena P; Gutierrez ML; Langerak AW; Fernandez-Navarro P; Orfao A; Almeida J;
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S24-34. PubMed ID: 20839335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL.
    Wang C; Amato D; Rabah R; Zheng J; Fernandes B
    Leuk Res; 2002 Dec; 26(12):1125-9. PubMed ID: 12443886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
    Scarfò L; Ghia P
    Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?
    Angelillo P; Capasso A; Ghia P; Scarfò L
    Eur J Intern Med; 2018 Dec; 58():2-6. PubMed ID: 30268574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
    Vander Meeren S; Heyrman B; Renmans W; Bakkus M; Maes B; De Raeve H; Schots R; Jochmans K
    Ann Hematol; 2018 Jul; 97(7):1219-1227. PubMed ID: 29492600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biclonal chronic lymphocytic leukemia.
    Hsi ED; Hoeltge G; Tubbs RR
    Am J Clin Pathol; 2000 Jun; 113(6):798-804. PubMed ID: 10874880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
    Durrieu F; Geneviève F; Arnoulet C; Brumpt C; Capiod JC; Degenne M; Feuillard J; Garand R; Kara-Terki A; Kulhein E; Maynadié M; Ochoa-Noguera ME; Plesa A; Roussel M; Eghbali H; Truchan-Graczyk M; de Carvalho Bittencourt M; Feugier P; Béné MC
    Cytometry B Clin Cytom; 2011 Nov; 80(6):346-53. PubMed ID: 21976156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
    Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
    Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal B-cell lymphocytosis: physiological entity or preliminary stage of chronic lymphocytic leukaemia?].
    Schindhelm RK; van Marwijk Kooy MR; Coenen JL; Huijgens PC; Kuiper-Kramer PA
    Ned Tijdschr Geneeskd; 2010; 154():A1520. PubMed ID: 20482911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization and Validation of an 8-Color Single-Tube Assay for the Sensitive Detection of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia Detected via Flow Cytometry.
    Dowling AK; Liptrot SD; O'Brien D; Vandenberghe E
    Lab Med; 2016 May; 47(2):103-11. PubMed ID: 27069028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.